| Quick Answer |
| • Mounjaro (tirzepatide) starts at 2.5 mg once a week for four weeks, then moves to 5 mg. • After that, a doctor can raise the dose by 2.5 mg at a time, with at least four weeks at each step: 5, 7.5, 10, 12.5, and 15 mg. • 15 mg once a week is the maximum. The earliest anyone can reach it is week 21. • For weight management, 5, 10, and 15 mg are the maintenance doses, and many users do well without ever reaching the top. • Every step is a doctor’s call, based on how well the medicine is working and how well the body is coping. |
Mounjaro is a once-a-week injection for adults with type 2 diabetes or excess weight, made by Eli Lilly and sold only on prescription. Its active ingredient is tirzepatide.
It works by acting like two hormones the gut releases after a meal (GLP-1 and GIP). These hormones tell the brain the body has eaten enough and slow down how fast the stomach empties. They also help the pancreas release insulin when blood sugar rises.
For a user, the effect is a quieter appetite. A smaller thali starts to feel like enough, and the pull towards the evening namkeen weakens.
In India, it is approved for type 2 diabetes and for long-term weight management in adults who meet the label criteria. It is meant to work alongside changes in eating and activity, never in place of them.
Mounjaro is a medicine you climb into. Nobody starts at full strength, and how far up the ladder a user goes is a medical decision, not a number printed on the box.
Mounjaro in India arrived in March 2025 as 2.5 mg and 5 mg vials. In August 2025, the KwikPen followed in all six strengths, and each Indian pen holds four fixed weekly doses. That gives the whole schedule a tidy rule of thumb: one pen, one step.
Mounjaro Dose Chart
The full Mounjaro dose chart has six strengths, from 2.5 mg to 15 mg, each injected once a week. Every step lasts at least four weeks before a doctor considers the next one.
| Weeks | Weekly dose | What this step is for |
|---|---|---|
| 1 to 4 | 2.5 mg | Starter dose. Lets the stomach and gut adjust. Not a treatment dose. |
| 5 to 8 | 5 mg | First maintenance dose. Many users stay here if it works well. |
| 9 to 12 | 7.5 mg | Stepping stone towards 10 mg. |
| 13 to 16 | 10 mg | Second maintenance dose. |
| 17 to 20 | 12.5 mg | Stepping stone towards 15 mg. |
| 21 onwards | 15 mg | Maximum dose. A ceiling, not a target for everyone. |
Read the week column as the earliest timing allowed, never as a deadline. The rules come from the US prescribing information for tirzepatide in weight management, the most detailed public version of the dosing label. It starts at 2.5 mg for four weeks, moves to 5 mg, and then rises in 2.5 mg steps only after at least four weeks on the current dose.
Plenty of users take longer. A doctor who holds a step for eight weeks because nausea has not settled is not slowing treatment down. That doctor is keeping it going.
The Six Dose Strengths Explained
The six strengths do different jobs. One starts treatment, three are maintenance doses for weight management, and two are bridges between them.
| Strength | Its job | Can a user stay on it long-term |
|---|---|---|
| 2.5 mg | Starter dose | No. The label calls it a dose for starting treatment only. |
| 5 mg | First maintenance dose | Yes, if it works and suits the user. |
| 7.5 mg | Bridge to 10 mg | Not listed as a maintenance dose for weight management. |
| 10 mg | Middle maintenance dose | Yes. |
| 12.5 mg | Bridge to 15 mg | Not listed as a maintenance dose for weight management. |
| 15 mg | Maximum dose | Yes. |
The starter dose exists for the stomach, not the scale. Because Mounjaro slows how fast the stomach empties, a small first dose gives the gut a month to get used to that before the real work begins.
Here is a detail most dose charts skip: the weight-loss trials never tested 7.5 mg or 12.5 mg as a destination. Participants were assigned 5, 10, or 15 mg, and the in-between strengths were only ever passed through on the way up.
That is why the weight-management label names only those three as maintenance doses. For type 2 diabetes, the ladder has the same rungs, and a doctor moves up when blood sugar needs more control.
How Long You Stay at Each Dose
A user stays at least four weeks on every step, and often longer. Four weeks is a floor set by the label, not a timer that forces the next increase.
The four-week rhythm has a biological reason. Half of each dose is still in the body about five days after the injection, so levels build up week on week.
According to the prescribing information, blood levels settle into a steady state after four weekly doses. Raising the dose earlier means judging a step the body has not finished taking.
A doctor may hold a step longer when nausea or constipation has not eased or when weight is still coming off steadily at the current dose.
Personal life matters too. A family wedding with a week of rich food is a poor time to test a new dose.
If you miss a dose, follow the simple rules on the label.
| Situation | What the label says |
|---|---|
| Missed a dose, and it is within 4 days (96 hours) | Take it as soon as you remember, then return to your usual day. |
| Missed a dose by more than 4 days | Skip it, and take the next dose on your usual day. |
| Want to change your injection day | Keep at least 3 days (72 hours) between two doses. |
| Tempted to double up | Never take two doses to make up for one. |
After several missed weeks in a row, speak to the doctor before restarting. Tolerance can fade over a long gap, so the doctor may restart at a lower step.
What Is the Maximum Dose?
The maximum dose of Mounjaro is 15 mg once a week for weight management and type 2 diabetes alike. No higher strength exists.
The earliest anyone can reach it is week 21, after five four-week steps. In India, each KwikPen delivers four fixed doses with no dial, so a dose cannot be nudged up between steps. A change of dose means a change of pen prescribed by a doctor.
Reaching 15 mg is an option a doctor can use. It is not a milestone a user is meant to hit.
Do You Need the Highest Dose?
No. The right maintenance dose is the lowest one that keeps working and that a user tolerates well. The label tells doctors to weigh exactly those two things, response and tolerability, when choosing it.
Response means more than the scale. A doctor looks at the waist, blood sugar, blood pressure, and how a user is eating and feeling. Tolerability means side effects a person can live with, week after week, without dreading the next injection.
What SURMOUNT showed at 5, 10, and 15 mg
The clearest evidence comes from SURMOUNT-1. It followed 2,539 adults with obesity or overweight, without diabetes, for 72 weeks, and India was one of its nine trial countries.
Every participant started at 2.5 mg and climbed in 2.5 mg steps every four weeks until reaching an assigned dose of 5, 10, or 15 mg. A fourth group received a placebo (a dummy injection).
All three doses beat placebo by a wide margin, and people on the higher doses lost up to 20% of their body weight. The more useful pattern sits in between.
Most of the benefit was already visible at 5 mg. Moving from 5 to 10 mg added a clear extra step, while moving from 10 to 15 mg added a much smaller one. The 10 mg and 15 mg groups finished close together.
Side effects did not climb in a straight line either. Nausea affected about one in four people on 5 mg and one in three on 10 mg, but no more on 15 mg than on 10 mg. On placebo, it was one in ten.
These are averages across thousands of people. Some users need 15 mg to get a good response, and some do well for years at 5 mg. The trial shows that a lower dose is a real option, not a lesser one.
Staying at a Lower Dose Long-Term
Yes, a lower dose can be a long-term plan, and 2026 brought the first trial designed to test it. What matters is whether the lower dose holds the result, not whether it matches the dose that produced it.
SURMOUNT-MAINTAIN took adults who had lost weight over 60 weeks on their highest tolerated dose (10 or 15 mg). It then randomly placed them on one of three paths for another year: continue that dose, step down to 5 mg, or switch to placebo.
Those who stayed on their full dose held their weight almost steady. Those who stepped down to 5 mg regained some, but far less than those switched to placebo.
About one in four in the 5 mg group regained enough to qualify for rescue treatment. On placebo, it was two in three.
Stopping altogether is the riskiest path. The placebo group shows what tends to happen when the medicine goes: much of the weight comes back.
Two caveats matter for Indian readers. The trial ran at 20 sites, all in the US, and one maintenance year is short for a lifelong condition. Its authors say it is still unclear which people do well on a reduced dose.
That question has a sharper edge in India. The 2025 revised Indian definition of obesity starts counting excess fat from a BMI above 23 and grades its seriousness by waist size and related health problems.
Indian guidance treats a waist of 90 cm or more in men and 80 cm or more in women as the point where belly fat raises risk. Yet Mounjaro’s Indian label uses global cut-offs for weight management: a BMI of 30, or 27 with a weight-related condition.
The ICMR-INDIAB study estimated 254 million Indian adults with generalized obesity and 351 million with abdominal obesity. Far more Indians carry excess fat at the waist than the scale alone suggests.
For an Indian user, a maintenance dose should be judged against the measuring tape and the blood report as much as the weighing scale. That judgment belongs to a doctor who sees the full picture.
Side Effects at Each Step
Mounjaro side effects tend to arrive with each new step and fade once the dose is stable. In the trials, digestive side effects were mostly mild to moderate and happened mostly while the dose was being raised.
| Step | What users commonly notice | What often helps |
|---|---|---|
| 2.5 mg (weeks 1 to 4) | Feeling full sooner, a smaller appetite, mild nausea | Smaller katoris; stopping at the first sign of fullness |
| 5 mg | Nausea returning for a few days; constipation or loose motions | Water spread through the day; fiber from dal, sabzi, and fruit |
| 7.5 to 10 mg | Nausea can be more noticeable for some; burping or acidity | Lighter, earlier dinners; going easy on fried snacks |
| 12.5 to 15 mg | Similar digestive effects, usually settling at a stable dose | Telling the doctor if symptoms do not ease |
The Indian plate matters here. Because the medicine slows the stomach, a heavy, oily meal (puri bhaji, pakoras with evening chai, a 10 pm biryani dinner) sits longer and is more likely to bring on nausea. Eating earlier and smaller is a practical adjustment, not a diet plan.
Some symptoms need a doctor promptly. Severe stomach pain that will not settle, pain spreading to the back, or pain under the right ribs can signal pancreatitis or gallbladder trouble.
Repeated vomiting or loose motions in an Indian summer can dehydrate a person quickly, and dehydration can strain the kidneys.
Two dose-step facts are easy to miss. Mounjaro can make oral contraceptive pills less reliable, and the label advises switching to a non-oral method, or adding a barrier method, for four weeks after starting and for four weeks after every dose increase.
Users who also take insulin or sulfonylureas for diabetes face a higher risk of low blood sugar, so those doses may need adjusting as Mounjaro climbs.
Mounjaro is not for everyone. People with a personal or family history of medullary thyroid cancer or of a rare inherited condition called MEN 2 should not use it, and it is stopped once a pregnancy is known.
Mounjaro vs. Ozempic Dosing Compared
Both medicines climb in four-week steps from a small starter dose, but their milligram numbers cannot be compared. Five milligrams of Mounjaro is not ten times stronger than 0.5 mg of Ozempic because they are different molecules acting on different receptors.
Ozempic (semaglutide) acts on the GLP-1 receptor alone, while Mounjaro acts on both GLP-1 and GIP receptors. In India, Ozempic launched in December 2025 for type 2 diabetes only. Semaglutide for weight management is sold separately as Wegovy.
| Comparison Factor | Mounjaro | Ozempic |
|---|---|---|
| Medicine | Tirzepatide | Semaglutide |
| Approved use in India | Type 2 diabetes and chronic weight management | Type 2 diabetes |
| Starter dose | 2.5 mg weekly for 4 weeks | 0.25 mg weekly for 4 weeks |
| Steps after that | 5, 7.5, 10, 12.5, 15 mg | 0.5, 1, 2 mg |
| Strengths launched in India | All six | 0.25, 0.5, and 1 mg |
| Maximum weekly dose | 15 mg | 2 mg |
| Missed-dose window | Within 4 days | Within 5 days |
The standard Ozempic dosage schedule, set out in its European product information, starts at 0.25 mg for four weeks, moves to 0.5 mg, and can rise to 1 mg and then 2 mg, each after at least four weeks. India’s launch stopped at 1 mg.
Neither ladder is better in the abstract. They are different medicines with different labels, and moving from one to the other is never a simple milligram conversion. A doctor decides where a user restarts.
| Conclusion |
| Mounjaro climbs from a 2.5 mg starter dose to a 15 mg maximum, with at least four weeks at every step. For weight management, 5, 10, and 15 mg are maintenance doses, and trial data shows lower doses can work well and help hold results. The right dose is the lowest one that works, chosen with a doctor. |
Frequently Asked Questions
1. What are the Mounjaro dose strengths?
Mounjaro comes in six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, each injected once a week. 2.5 mg is a starter dose only. For weight management, 5, 10, and 15 mg are maintenance doses, and 7.5 and 12.5 mg are steps between them. All six are available in India as KwikPens.
2. How many weeks at each dose before increasing?
At least four weeks. A doctor raises the dose by 2.5 mg only after a user has spent at least four weeks on the current dose. Many doctors wait longer if side effects have not settled or if weight is still coming off steadily at that step.
3. What is the maximum Mounjaro dose?
The maximum Mounjaro dose is 15 mg once a week. The earliest it can be reached is week 21 of treatment, after five four-week steps. Many users never need it, and no higher strength exists.
4. Do I need to reach the highest dose to lose weight?
No. In the SURMOUNT-1 trial, all three maintenance doses (5, 10, and 15 mg) worked far better than placebo, and the 10 mg and 15 mg groups finished close together. The right dose is the lowest one that works and is well tolerated, decided with a doctor.
5. Can I stay on a lower dose long-term?
Often, yes, under medical supervision. The 2026 SURMOUNT-MAINTAIN trial found that stepping down to 5 mg after weight loss kept much of the result, with far less regain than stopping. Staying on the full dose held weight most steadily, and stopping completely led to the most regain.
| Medical Disclaimer |
| This article is for general education and is not medical advice. Mounjaro and Ozempic are prescription-only medicines in India and must be used only under the supervision of a qualified doctor. Do not start, change, or stop any dose without medical advice. Speak to your doctor about your own health, weight, and treatment options. |